On January 6, 2023, the Food and Drug Administration approved the new Alzheimer’s drug lecanemab, which has been shown in clinical trials to slow cognitive decline in patients with mild cognitive impairment or early Alzheimer’s … [Read more...]
Print This PageNational Coverage Determination Analysis on Treatment for Alzheimer’s Disease
July 14, 2021 by
CMS NEWS (released on 7/12/2021 by CMS) CMS Opens National Coverage Determination Analysis on Treatment for Alzheimer’s Disease Thorough Process Will Enable Careful Consideration of Coverage and Incorporate Public … [Read more...]
Print This PageFDA Approves New Alzheimer’s Drug—But Does it Work?
June 11, 2021 by
Q. My family has a history of Alzheimer’s disease. We heard that a new drug for Alzheimer’s was just approved by the FDA. The process for its approval seemed kind of fast and it seems that Alzheimer’s drugs in the past have been … [Read more...]
Print This Page
